Glucosamine hydrochloride
Based on 12 publication(s) in Google Scholar
Glucosamine hydrochloride (D-Glucosamine hydrochloride) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement. Glucosamine hydrochloride also is a natural constituent of glycosaminoglycans in the cartilage matrix and synovial fluid, which when administered exogenously, exerts pharmacological effects on osteoarthritic cartilage and chondrocytes.
For research use only. We do not sell to patients.
- Purity: 98.0%
- CAS No.: 66-84-2
- Formula: C6H14ClNO5
- Molecular Weight:215.63
-
Storage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications Citing Use of MedChemExpress (MCE) Glucosamine hydrochloride
More- Nature. 2025 Jul;643(8070):192-200. [Abstract]
- Mil Med Res. 2025 Jul 28;12(1):39. [Abstract]
- Theranostics. 2021 Mar 24;11(12):5650-5674. [Abstract]
- Microbiome. 2019 Mar 20;7(1):43. [Abstract]
- Cell Rep. 2025 Sep 10;44(9):116249. [Abstract]
- Int Immunopharmacol. 2024 Oct 18;143(Pt 2):113427. [Abstract]
- Artif Cells Nanomed Biotechnol. 2026 Dec;54(1):248-275. [Abstract]
- Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G746-G759. [Abstract]
- Diabetes Metab Syndr Obes. 2025 Jul 29:18:2573-2584. [Abstract]
- Biocell. 2025 Sep 25;49(9):1711-1731.
- bioRxiv. 2026 Jan 26.
- Laurea Magistrale in Biomedical Engineering, Politecnico di Milano. 2019 Jun.
-
Cell Proliferation/Viability Assay
-
Bio/Physico-chemical Assay
-
WB
All Endogenous Metabolite Isoforms
More
Biological Activity
|
Human Endogenous Metabolite |
Microbial Metabolite |
Glucosamine hydrochloride (D-Glucosamine hydrochloride) exhibits dose-dependent DPPH antioxidant activity[2].
Glucosamine hydrochloride treatment of Short-term (4 h) inhibits HIF-1α at the protein level, decreases phosphorylation of p70S6K and S6, translation-related proteins[3].
Glucosamine hydrochloride significantly decreases renal expression of α-smooth muscle actin, collagen I, and fibronectin in the obstructed kidneys and TGF-β1-treated renal cells[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 66-84-2
-
Appearance Solid
-
Molecular Weight 215.63
-
Formula C6H14ClNO5
-
Color White to off-white
-
SMILES
O=C[C@H](N)[C@H]([C@@H]([C@@H](CO)O)O)O.Cl
-
Synonyms
D-(+)-Glucosamine hydrochloride; Chitosamine hydrochloride
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (12)
-
Journal Impact Factor
-
Most Recent
-
Nature
2025 Jul;643(8070):192-200. PMID: 39695227 -
Mil Med Res
Accelerating cartilage regeneration with DNA-SF hydrogel sustained release system-based cartilage organoids. [Abstract]2025 Jul 28;12(1):39. PMID: 40722047 -
Theranostics
Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. [Abstract]2021 Mar 24;11(12):5650-5674. PMID: 33897873
Glucosamine hydrochloride purchased from MedChemExpress. Usage Cited in: Theranostics. 2021 Mar 24;11(12):5650-5674. [Abstract]
LUAD cells were treated with erastin with or without Fer-1 or DFO, in the presence or absence of GlcN (5 mM). Cell death was measured after treatment for 24 h.
Glucosamine hydrochloride purchased from MedChemExpress. Usage Cited in: Theranostics. 2021 Mar 24;11(12):5650-5674. [Abstract]
LUAD cells were treated with erastin with or without Fer-1 or DFO, in the presence or absence of GlcN (5 mM). MDA was measured after treatment for 16 h.
Glucosamine hydrochloride purchased from MedChemExpress. Usage Cited in: Theranostics. 2021 Mar 24;11(12):5650-5674. [Abstract]
Metabolites downstream of GFPT1 restore YAP alteration by erastin. p-YAPS127, O-YAPT241 and YAP were measured by IB in H1975 cells treated with or without erastin, glucose, GlcN (5 mM) or GlcNAc for 8 h.
-
Microbiome
Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites. [Abstract]2019 Mar 20;7(1):43. PMID: 30890187 -
Cell Rep
The hexosamine biosynthetic pathway drives tumor immune evasion via translational control of PD-L1 at the elongation level. [Abstract]2025 Sep 10;44(9):116249. PMID: 40938752 -
Int Immunopharmacol
2024 Oct 18;143(Pt 2):113427. PMID: 39426230 -
Artif Cells Nanomed Biotechnol
Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study. [Abstract]2026 Dec;54(1):248-275. PMID: 42331338 -
Am J Physiol Gastrointest Liver Physiol
Glucose metabolism through the hexosamine biosynthetic pathway drives hepatic de novo lipogenesis via promoting N-linked protein glycosylation. [Abstract]2025 Jun 1;328(6):G746-G759. PMID: 40331866 -
Diabetes Metab Syndr Obes
2025 Jul 29:18:2573-2584. PMID: 40755745 -
-
-
Solvent & Solubility
DMSO : 100 mg/mL (463.76 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 50 mg/mL (231.88 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (11.59 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (11.59 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (463.76 mM); Clear solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Bruyère O, et al. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S12-7. [Content Brief]
[2]. Jamialahmadi K, et al. Protective effects of glucosamine hydrochloride against free radical-induced erythrocytes damage. Environ Toxicol Pharmacol. 2014 Jul;38(1):212-9. [Content Brief]
[3]. Jo JR, et al. Short-term treatment with glucosamine hydrochloride specifically downregulates hypoxia-inducible factor-1α at the protein level in YD-8 human tongue cancer cells. Int J Oncol. 2014 May;44(5):1699-706. [Content Brief]
[4]. Park J, et al. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling. J Mol Med (Berl). 2013 Nov;91(11):1273-84. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O / DMSO | 1 mM | 4.6376 mL | 23.1879 mL | 46.3757 mL | 115.9393 mL |
| 5 mM | 0.9275 mL | 4.6376 mL | 9.2751 mL | 23.1879 mL | |
| 10 mM | 0.4638 mL | 2.3188 mL | 4.6376 mL | 11.5939 mL | |
| 15 mM | 0.3092 mL | 1.5459 mL | 3.0917 mL | 7.7293 mL | |
| 20 mM | 0.2319 mL | 1.1594 mL | 2.3188 mL | 5.7970 mL | |
| 25 mM | 0.1855 mL | 0.9275 mL | 1.8550 mL | 4.6376 mL | |
| 30 mM | 0.1546 mL | 0.7729 mL | 1.5459 mL | 3.8646 mL | |
| 40 mM | 0.1159 mL | 0.5797 mL | 1.1594 mL | 2.8985 mL | |
| 50 mM | 0.0928 mL | 0.4638 mL | 0.9275 mL | 2.3188 mL | |
| 60 mM | 0.0773 mL | 0.3865 mL | 0.7729 mL | 1.9323 mL | |
| 80 mM | 0.0580 mL | 0.2898 mL | 0.5797 mL | 1.4492 mL | |
| 100 mM | 0.0464 mL | 0.2319 mL | 0.4638 mL | 1.1594 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.